Global Life Sciences - progress in making their websites accessible

17 Mar 2020 | Index | Accessibility

Adam Turner
  • Tweet this item
  • share this item on Linkedin

At Sitemorse we published our 2020 Q1 Global Life Sciences INDEX this week. The INDEX has been published quarterly since 2009 and ranks the websites of nearly 200 companies based on User Experience, Search Engine Optimisation and Governance, Risk and Compliance.

Our Q1 2020 INDEX was produced on 9th January 2020 and in its preparation, we ran over 95 million tests checks and measures across over 290,000 URLs.

Congratulations go to Apotex for taking first place. Also, congratulations are due to Sawai Pharmaceutical for being the most improved.

If we focus purely on Accessibility, then we see that

  • Only 2 companies scored 7 or higher.
  • 84% scored 4 or less.
  • 35% actually scored zero

Comparing results with last quarter, only 16 companies improved their accessibility score from the last quarter, while 20 scored lower. 6 companies failed all of the WCAG 2.1 Level A and AA tests on every single page.

Making websites accessible is law - in the US there is the Americans with Disabilities Act (ADA) and in the UK the Equalities Act 2000.

The Top Ten Global Life Sciences Websites are:

  1. Apotex
  2. Medivir Group
  3. Cytogen
  4. Ligand Pharmaceuticals
  5. United Therapeutics
  6. Dainippon Sumitomo
  7. Baxter Healthcare UK
  8. Yakult UK
  9. Zambon
  10. Galenica AG

Five Most Improved

  • Sawai Pharmaceutical
  • Teva Pharmaceutical Industries Ltd
  • Gedeon Richter
  • Aptalis Pharma
  • Cipla

The full 2020 Q1 Global Life Sciences results can be found here: Sitemorse Global Life Sciences INDEX